B7-33 Peptide: A potential catalyst in fibrosis and cardiovascular research
B7-33 is engineered to retain the core functionalities of H2-relaxin while simplifying its structure to a single-chain format.
By Amh Voices
Apr. 2, 2025
Harare residents abandon taps for shared boreholes, as city water crisis deepens
Local News
Apr. 24, 2026
Ariston Holdings seeks shareholder lifeline... move set to stabilise finances as liquidity strain bites
Business Digest
Apr. 24, 2026




